Pazopanib - dilemmas in kidney cancer treatment

Journal Title: OncoReview - Year 2013, Vol 3, Issue 4

Abstract

Progress in metastatic renal cell carcinoma treatment is generally based on new registered drugs. This brings improvement of results but it also needs the choice of proper drug. The decision is especially important in initial therapy where there are few drugs with similar properties. The choice of drug in first line is based on prognostic factors and clinical profiles of drug and patient. Important are also patient’s expectations connected with treatment. COMPARZ trail shows results of comparison between sunitinib and pazopanib which both are given in first line treatment of mRCC. Based on this the decision of choosing proper drug seems to be easier.

Authors and Affiliations

Piotr Tomczak

Keywords

Related Articles

Post-transplant care after allogeneic hematopoietic stem cell transplantation

Around 25,000 people annually worldwide are subject to the procedure of allogeneic hematopoietic stem cell transplantation (HSCT). As the number of procedures has been on the rise, post-transplant care is becoming an ess...

Compliance, adherence, persistence – przyczyny i konsekwencje niestosowania się pacjentów do zaleceń terapeutycznych

Nieprzestrzeganie zaleceń terapeutycznych znajduje się wśród najpoważniejszych problemów zdrowotnych ludzkości. Zostało uznane za jedną z najważniejszych przeszkód w osiąganiu korzyści z terapii opartej na aktualnej wied...

Zastosowanie echokardiografii w onkologii – uwagi praktyczne

Artykuł przedstawia współczesne zastosowanie echokardiografii w wykrywaniu pierwotnych i przerzutowych nowotworów serca oraz w ocenie ryzyka sercowo-naczyniowego związanego z farmakologicznym i zabiegowym leczeniem nowot...

Rehabilitation of patients with cancer of the respiratory system

Many patients with lung cancer have concomitant chronic obstructive pulmonary disease and heart diseases. The planned anticancer therapy should be individualized in relationship of patient’s cardiac and pulmonary conditi...

Mental disorders in cancer patients - clinical approach

Cancer patient is struggling not only with the primary disease, but also is exposed to emotional states that at unfavorable conditions and heavy burden can lead to depression, increased anxiety, and in consequence cause...

Download PDF file
  • EP ID EP67737
  • DOI -
  • Views 219
  • Downloads 0

How To Cite

Piotr Tomczak (2013). Pazopanib - dilemmas in kidney cancer treatment. OncoReview, 3(4), 257-261. https://europub.co.uk/articles/-A-67737